Aggregation of features of the metabolic syndrome is associated with increased prevalence of chronic complications in Type 2 diabetes
Version of Record online: 17 FEB 2004
Volume 21, Issue 3, pages 252–255, March 2004
How to Cite
Costa, L. A., Canani, L. H., Lisbôa, H. R. K., Tres, G. S. and Gross, J. L. (2004), Aggregation of features of the metabolic syndrome is associated with increased prevalence of chronic complications in Type 2 diabetes. Diabetic Medicine, 21: 252–255. doi: 10.1111/j.1464-5491.2004.01124.x
- Issue online: 17 FEB 2004
- Version of Record online: 17 FEB 2004
- Accepted 20 June 2003
- metabolic syndrome;
- Type 2 diabetes;
- chronic complications
Aims To investigate the association of features of the metabolic syndrome with the prevalence of chronic complications.
Methods A cross-sectional study was conducted with 548 patients with Type 2 diabetes mellitus (DM). Metabolic syndrome was diagnosed in the presence of at least two of the following: hypertension, dyslipidaemia, obesity, and microalbuminuria.
Results Patients with the metabolic syndrome (85%) had a higher prevalence of peripheral vascular disease (PVD) (35% vs. 18%), retinopathy (44% vs. 20%), distal sensory neuropathy (DSN) (44% vs. 24%), micro- and macroalbuminuria (38% vs. 28%) and coronary artery disease (CAD) (53% vs. 36%). The more metabolic syndrome features (none/one, two, three or four), the higher the proportion of diabetes complications: PVD 18%, 31%, 37% and 38%; stroke 1.0%, 4.5%, 5.9% and 11.3%; retinopathy 20%, 38%, 42% and 64%; DSN 24%, 32%, 49% and 57%; micro- and macroalbuminuria 28%, 36% and 41%; and CAD 36%, 44%, 52% and 60% (P < 0.05).
Conclusions The metabolic syndrome and the aggregation of its components were significantly associated with macro- and microvascular complications in Type 2 DM patients.